Rare Disease Company Coalition established

By The Science Advisory Board staff writers

May 14, 2021 -- A coalition of pharmaceutical and biosciences companies has launched a new organization to educate policymakers on the challenges they face bringing therapies to the market for small patient populations.

The Rare Disease Company Coalition represents life science companies that have brought 22 treatments to the market and have more than 160 rare disease development programs, according to the group. In 2020, coalition members invested more than $4.1 billion in research and development, representing approximately 65% of their annual operating budgets.

Working with policymakers to establish long-term, consistent, equitable and sustainable research incentives for rare diseases will be among the coalition's objectives.

Founding members of the Rare Disease Company Coalition include Acceleron Pharma, Aeglea BioTherapeutics, Agios Pharmaceuticals, Alnylam Pharmaceuticals, Harmony Biosciences, Orchard Therapeutics, Orphazyme US, Sarepta Therapeutics, Taysha Gene Therapies, and Ultragenyx Pharmaceutical.

New report investigates availability of orphan drugs
Findings of a new study commissioned by the National Organization for Rare Disorders explores the effect of patents and exclusivity on orphan drug products.
Global Genes produces series on gene therapy, editing
Rare disease patient advocacy organization Global Genes will publish a multimedia series about advances in gene therapy and gene editing technology throughout...
Development 'cookbooks' could speed up gene therapy
Great strides have been made in the development of gene editing tools in the past decade, but translating the technology into real therapies to treat...

Copyright © 2021 scienceboard.net


Conferences
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter